NCT/Study#

M20-866

A Phase 1b Dose Escalation Study of Lemzoparlimab (TJ011133) in Combination with Azacitidine and/or Venetoclax in Subjects with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS

A Phase 1b Dose Escalation Study of Lemzoparlimab (TJ011133) in Combination with
Azacitidine and/or Venetoclax in Subjects with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS

DISEASE GROUP:
Leukemia
current phase:
Phase I
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: